| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JSO.23109 |
| P698 | PubMed publication ID | 22488197 |
| P50 | author | Yataro Daigo | Q114328026 |
| P2093 | author name string | Keidai Ishikawa | |
| Masato Aragaki | |||
| Mitsuhito Kaji | |||
| Tatsuya Kato | |||
| Masaaki Sato | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Identification of common differentially expressed genes in urinary bladder cancer | Q21135503 | ||
| CDC27Hs colocalizes with CDC16Hs to the centrosome and mitotic spindle and is essential for the metaphase to anaphase transition | Q24316218 | ||
| The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis | Q24656114 | ||
| APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit | Q27936633 | ||
| Cancer statistics, 2001 | Q28189339 | ||
| Mitotic kinases as regulators of cell division and its checkpoints | Q28202545 | ||
| The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint | Q28305958 | ||
| The anaphase-promoting complex: proteolysis in mitosis and beyond | Q28610045 | ||
| Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint | Q28631721 | ||
| Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression | Q29615223 | ||
| A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B | Q29620071 | ||
| Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs | Q31137900 | ||
| The mitotic machinery as a source of genetic instability in cancer | Q33711329 | ||
| Regulation of the APC and the exit from mitosis | Q33772649 | ||
| Identification and validation of genes involved in cervical tumourigenesis | Q33825832 | ||
| The spindle checkpoint, aneuploidy, and cancer | Q33976673 | ||
| Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application | Q35783088 | ||
| Anaphase-promoting complex-dependent proteolysis of cell cycle regulators and genomic instability of cancer cells | Q36002265 | ||
| Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer | Q38314637 | ||
| Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling | Q38522674 | ||
| Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer | Q40267243 | ||
| A new Mad2-interacting domain of Cdc20 is critical for the function of Mad2-Cdc20 complex in the spindle assembly checkpoint | Q42533669 | ||
| Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20. | Q48863501 | ||
| Dual inhibition of sister chromatid separation at metaphase | Q48873086 | ||
| A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. | Q51584233 | ||
| Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer. | Q51985184 | ||
| Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas. | Q53361610 | ||
| Aneuploidy and cancer | Q56224730 | ||
| P433 | issue | 4 | |
| P921 | main subject | non-small-cell lung carcinoma | Q3658562 |
| overexpression | Q61643320 | ||
| P304 | page(s) | 423-430 | |
| P577 | publication date | 2012-04-04 | |
| P1433 | published in | Journal of Surgical Oncology | Q1919535 |
| P1476 | title | Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients. | |
| P478 | volume | 106 |
| Q38846085 | A comprehensive analysis of CDC20 overexpression in common malignant tumors from multiple organs: its correlation with tumor grade and stage |
| Q33842900 | APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction |
| Q56369816 | Aneuploidy: Cancer strength or vulnerability? |
| Q64095659 | CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β‑catenin signaling pathway |
| Q60928590 | CDC20 overexpression leads to poor prognosis in solid tumors: A system review and meta-analysis |
| Q36952921 | CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer |
| Q50709265 | CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression. |
| Q94546926 | CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma |
| Q35857620 | CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma |
| Q33750165 | Cdc20 and securin overexpression predict short-term breast cancer survival. |
| Q41084291 | Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex |
| Q33584460 | Cdc20: a potential novel therapeutic target for cancer treatment |
| Q38710141 | Cell division cycle 20 overexpression predicts poor prognosis for patients with lung adenocarcinoma |
| Q49584310 | Cell division cycle 20 promotes cell proliferation and invasion and inhibits apoptosis in osteosarcoma cells |
| Q60912671 | Defining a Characteristic Gene Expression Set Responsible for Cancer Stem Cell-Like Features in a Sub-Population of Ewing Sarcoma Cells CADO-ES1 |
| Q33771364 | Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma |
| Q36751768 | Downregulation of CDC27 inhibits the proliferation of colorectal cancer cells via the accumulation of p21Cip1/Waf1. |
| Q47636038 | E3 ubiquitin ligases in cancer and implications for therapies |
| Q64937486 | Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis. |
| Q37630882 | Elevated transcriptional levels of aldolase A (ALDOA) associates with cell cycle-related genes in patients with NSCLC and several solid tumors |
| Q37587404 | Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis |
| Q26998944 | Functional characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligases in tumorigenesis |
| Q89823382 | GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer |
| Q38456346 | Global analysis of chromosome 1 genes among patients with lung adenocarcinoma, squamous carcinoma, large-cell carcinoma, small-cell carcinoma, or non-cancer |
| Q35153105 | Global gene expression analysis of canine cutaneous mast cell tumor: could molecular profiling be useful for subtype classification and prognostication? |
| Q44010823 | High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma |
| Q53091942 | High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer. |
| Q55625808 | Hub genes and key pathways of non-small lung cancer identified using bioinformatics. |
| Q89718081 | Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis |
| Q37020724 | Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis. |
| Q94475251 | Identification of biomarkers for the transition from low-grade glioma to secondary glioblastoma by an integrated bioinformatic analysis |
| Q89495672 | Identification of differentially expressed protein-coding genes in lung adenocarcinomas |
| Q98778911 | Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis |
| Q54112056 | Identification of potential diagnostic and prognostic biomarkers in non-small cell lung cancer based on microarray data. |
| Q54977757 | Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. |
| Q35751484 | Impaired Cell Cycle Regulation in a Natural Equine Model of Asthma. |
| Q58494280 | Implications of alternative routes to APC/C inhibition by the mitotic checkpoint complex |
| Q36782357 | Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells |
| Q38717782 | Inhibition of Cell Survival by Curcumin Is Associated with Downregulation of Cell Division Cycle 20 (Cdc20) in Pancreatic Cancer Cells |
| Q26740196 | Insights into APC/C: from cellular function to diseases and therapeutics |
| Q36127680 | Integrated Analysis of DNA Methylation and mRNA Expression Profiles Data to Identify Key Genes in Lung Adenocarcinoma. |
| Q92421651 | Interplay between Phosphatases and the Anaphase-Promoting Complex/Cyclosome in Mitosis |
| Q64093755 | Overexpression of ASPM, CDC20, and TTK Confer a Poorer Prognosis in Breast Cancer Identified by Gene Co-expression Network Analysis |
| Q64099015 | Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma |
| Q52884318 | Overexpression of Cdc20 in clinically localized prostate cancer: Relation to high Gleason score and biochemical recurrence after laparoscopic radical prostatectomy. |
| Q33420092 | Proteins of the mitotic checkpoint and spindle are related to chromosomal instability and unfavourable prognosis in patients with myelodysplastic syndrome |
| Q26781203 | Regulation of Bim in Health and Disease |
| Q91474045 | Robust network-based regularization and variable selection for high-dimensional genomic data in cancer prognosis |
| Q52352276 | SUMO targets the APC/C to regulate transition from metaphase to anaphase. |
| Q43210374 | Screening feature genes of lung carcinoma with DNA microarray analysis |
| Q39741084 | Screening of biomarkers for prediction of response to and prognosis after chemotherapy for breast cancers |
| Q35688708 | Targeting Cdc20 as a novel cancer therapeutic strategy |
| Q90731555 | Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes |
| Q92651169 | The Anaphase Promoting Complex/Cyclosome (APC/C): A Versatile E3 Ubiquitin Ligase |
| Q92023091 | The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma |
| Q90943372 | The anaphase-promoting complex: A key mitotic regulator associated with somatic mutations occurring in cancer |
| Q58603880 | Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients |
| Q94475258 | Upregulation of cell division cycle 20 in cisplatin resistance-induced epithelial-mesenchymal transition in osteosarcoma cells |
| Q35114280 | Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours |
| Q39396240 | inFRank: a ranking-based identification of influential genes in biological networks |
Search more.